Cook Childrens Health Care System

Fort Worth, Texas 79104

11 studies enrolling now · 37 studies all time

What they study most

Adenovirus, Allan-Herndon-Dudley Syndrome, Anesthesia, Brain Tumor, Catheter-Related Infections, Children, Classic Congenital Adrenal Hyperplasia, Congenital Adrenal Hyperplasia, Congenital Anomaly, Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation, Cytomegalovirus (CMV)

Studies at this site

• Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age — Recruiting now
• A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH) — Recruiting now
• KiteLock 4% EDTA Lock Solution for the Prevention of Occlusions in Children With Intestinal Failure — Recruiting now
• A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT) — Recruiting now
• Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib — Recruiting now
• Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH) — Recruiting now
• The Pediatric Anesthesia Quality Improvement Project — Recruiting now
• A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy — Running, not enrolling
• Expanded Access Program for Tiratricol in Patients With Monocarboxylate Transporter 8 Deficiency — Available (expanded access)
• Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG) — Running, not enrolling
• Occlutech AFR Fontan Study — Starting soon
• Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma — Running, not enrolling
• Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells — Running, not enrolling
• Neuroblastoma Precision Trial — Running, not enrolling
• Copper Histidinate Treatment for Menkes Disease — APPROVED_FOR_MARKETING
• OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome — Enrolling by invitation
• NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922) — Completed
• Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome — Running, not enrolling
• Ex-vivo Confocal Imaging and Proteomic Profiling to Determine Treatment Response in Children With IBD — Starting soon
• A Study to Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children <6 Years With T1D — Completed
• An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome — Completed
• MIBG With Dinutuximab +/- Vorinostat — Completed
• Expanded Access Protocol for Adults and Pediatric Patients With Sickle Cell Disease Who Have No Alternative Treatment Options — NO_LONGER_AVAILABLE
• A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF) — Completed
• A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma — Completed
• A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation — Completed
• Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations — Withdrawn before enrolling
• A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials — Stopped early
• A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) — Completed
• 131I-MIBG Alone VS. 131I-MIBG With Vincristine and Irinotecan VS131I-MIBG With Vorinostat — Completed
• Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease — NO_LONGER_AVAILABLE
• Post-Marketing Assessment of Immunogenicity and Safety of Unituxin® in High-Risk Neuroblastoma Patients — Stopped early
• Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump — Completed
• A Retrospective Study of the Natural History of Patients With Severe Perinatal and Infantile Hypophosphatasia (HPP) — Completed
• SF1126 for Patients With Relapsed or Refractory Neuroblastoma — Stopped early
• Efficacy and Safety of Ultratrace™ Iobenguane I 131 in Neuroblastoma — Withdrawn before enrolling
• Clobazam in Patients With Lennox-Gastaut Syndrome — Completed